Cardio-metabolic Diseases in Immigrants and Ethnic Minorities: From Epidemiology to New Prevention Strategies

计划入组 202 人 · 首次发布于 2023 年 11 月 14 日

Circadian Clocks and Eating Patterns (Cohort)

计划入组 38 人 · 首次发布于 2020 年 11 月 24 日

Impact of a Regional Program Agir Sur Sa SantE

计划入组 1,000 人 · 首次发布于 2015 年 6 月 23 日

NPY2r Agonist (cardio-renal-metabolic diseases)

NaCT inhibitors (metabolic diseases)

antibody therapeutics (metabolic diseases)

METABOLIC THERAPY, INC.

United States

Metabolic Technologies, Inc.

United States

Swiss Cardio Technologies AG

Switzerland

MultiOmic Health Partners with Serbia's BIO4 Campus to Develop AI-Driven Precision Medicine for Cardio-Renal-Metabolic Diseases

Augustine Therapeutics Appoints Rie Schultz Hansen as CSO, Establishes Copenhagen Subsidiary to Advance HDAC6 Inhibitor Pipeline

Integrated Cardio-Renal-Metabolic Care Models Face Implementation Challenges Despite Promise